drugset / Trial / NCT00992602

Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer

NCT00992602 ↗

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies how well giving liposomal cytarabine and high-dose methotrexate works in treating patients with breast cancer that has spread to the central nervous system. Drugs used in chemotherapy, such as liposomal cytarabine and methotrexate, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving liposomal cytarabine with high-dose methotrexate may kill more tumor cells.

Timeline

Start
2011-04
Primary completion
2013-06
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule — Intravenous
Subject liposomal cytarabine Unknown — Intrathecal